TTC19-TOM1L2 Fusion FISH Probe
The TTC19-TOM1L2 Fusion FISH Probe is used to confirm a fusion of the TTC19 and TOM1L2 genes. The fusion of the TTC19 and TOM1L2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TTC19-TOM1L2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TTC19-TOM1L2-20-AQAQ | 20 (40 μL) | 200 μL |
|
TTC19 Gene Summary
This gene encodes a protein with a tetratricopeptide repeat (TPR) domain containing several TPRs of about 34 aa each. These repeats are found in a variety of organisms including bacteria, fungi and plants, and are involved in a variety of functions including protein-protein interactions. This protein is embedded in the inner mitochondrial membrane and is involved in the formation of the mitochondrial respiratory chain III. It has also been suggested that this protein plays a role in cytokinesis. Mutations in this gene cause mitochondrial complex III deficiency. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2012]
Gene Name: Tetratricopeptide Repeat Domain 19
Chromosome: CHR17: 15902693 -15932723
Locus: 17p12
TOM1L2 Gene Summary
This gene belongs to a small gene family whose members have an N-terminal VHS domain followed by a GAT domain; domains which typically participate in vesicular trafficking. The canonical protein encoded by this gene also has a C-terminal clathrin binding motif. This protein has been shown to interact with Tollip, clathrin and ubiquitin and is thought to play a role in endosomal sorting. This gene resides in the 3.7 Mb deletion of chromosome region 17p11.2 that is associated with Smith-Magenis syndrome. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Apr 2017]
Gene Name: Target Of Myb1 Like 2 Membrane Trafficking Protein
Chromosome: CHR17: 17746821 -17875784
Locus: 17p11.2
Gene Diseases
The TTC19 TOM1L2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|